Table 2.
K i (nM) | Other targets | References | |
---|---|---|---|
Agonist | |||
AM 1241 | 3.4 | TRPA1 | [16, 17] |
JWH 133 | 3.4 | TRPV1 | [18, 19] |
GW 405833 | 3.6–3.92 | – | [20] |
JWH 015 | 13.8 | – | [8] |
HU 308 | 22.7 | – | [21] |
L-759,633 | 6.4 | – | [22] |
L-759,656 | 11.8 | – | [22] |
SER 601 | 6.3 | – | [23] |
GP 1a | 0.037 | – | [24] |
GP 2a | 7.6 | – | [24] |
CB 65 | 3.3 | – | [25] |
HU 210 | 0.061–0.52 | CB1, GPR55, 5-HT2 | [9, 26, 27] |
CP 55,940 | 0.6–5.0 | CB1, GPR55 | [26, 28] |
WIN 55, 212-2 | 62.3 | CB1,TRPA1 | [9, 17, 28] |
Antagonist | |||
SR144528 | 0.6–4.1 | – | [22, 29] |
AM 630 | 5.6–31.2 | TRPA1 | [22, 30] |
JTE907 | 35.9 | – | [31] |
– This compound is not known to activate other receptors besides CB2
TRP transient receptor potential ion channel